Feb 13 (Reuters) - BioXcel Therapeutics Inc BTAI.O :
* BIOXCEL THERAPEUTICS ANNOUNCES TERMINATION OF PROPOSED
PUBLIC
OFFERING
* TERMINATED ITS PROPOSED PUBLIC OFFERING OF $60.0 MILLION
OF
SHARES OF ITS COMMON STOCK
* CURRENT MARKET CONDITIONS ARE NOT CONDUCIVE FOR AN
OFFERING ON
TERMS THAT WOULD BE IN BEST INTERESTS OF STOCKHOLDERS
* INTENDS TO FOCUS ON ITS UPCOMING MEETING WITH FDA ON FEB
20, FOR
ITS PHASE 3 TRANQUILITY AT HOME TRIAL
Source text for Eikon: ID:nGNX2539L2
Further company coverage: BTAI.O
((Reuters.Briefs@thomsonreuters.com;))